BIOLINERX LTD's ticker is BLRX and the CUSIP is 09071M205. A total of 21 filers reported holding BIOLINERX LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200,866 | +14.1% | 110,366 | 0.0% | 0.00% | +50.0% |
| Q2 2023 | $176,034 | +79.9% | 110,366 | 0.0% | 0.00% | +100.0% |
| Q1 2023 | $97,839 | +46.3% | 110,366 | -2.6% | 0.00% | 0.0% |
| Q4 2022 | $66,886 | -30.5% | 113,366 | +9.0% | 0.00% | -50.0% |
| Q3 2022 | $96,230 | -27.6% | 104,032 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $133,000 | -25.3% | 104,032 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $178,000 | – | 104,032 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,686,375 | $2,884,000 | 0.18% |
| Senvest Management, LLC | 451,205 | $772,000 | 0.05% |
| Cutter & CO Brokerage, Inc. | 17,799 | $30,000 | 0.01% |
| Opaleye Management Inc. | 16,667 | $29,000 | 0.01% |
| Psagot Value Holdings Ltd. | 117,000 | $200,000 | 0.01% |
| Orbimed Advisors | 69,240 | $118,000 | 0.00% |
| MORGAN STANLEY | 565,114 | $966,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 18,973 | $32,000 | 0.00% |
| LPL Financial LLC | 19,876 | $34,000 | 0.00% |
| Asset Dedication, LLC | 366 | $1,000 | 0.00% |